Search Results - progenics
Progenics Pharmaceuticals (NASDAQ:PGNX) released its fourth-quarter results today, and the company was able to decrease its losses in the fourth quarter from last year, ending down by $639,000, or 2 cents a share.
Revenue for the quarter was over double it wa...
Healthcare (Mar 15th, 10)
Healthcare (Mar 15th, 10)
